Executive Summary: The global azacitidine market was valued at USD 90.24 billion in 2024 and is expected to reach USD 165.79 billion by 2032. During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.90%, primarily driven by increasing geriatric population. This growth is driven by factors such as higher disease incidence, longer life expectancy and less...